TORONTO, ON--(Marketwired - Jan 8, 2014) - Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce through its wholly-owned subsidiary, AllStar Health Brands Inc. that the initial order from Victory Brands, one of Canada's leading distributors of Health, Fitness and Nutrition products for its TapouT has sold out.
Based on the success of this initial sales effort, Axxess and Victory are preparing a more comprehensive marketing campaign aimed at expansion into larger retail outlets.
Ian Bell, President of Victory Brands, stated: "We are pleased that this initial order has sold out so quickly, and look forward to growing the brand across Canada. Our marketing team here at Victory believe the Canadian market is very receptive to the growth of this brand, and we are working closely with Axxess to ramp up sales very quickly."
Daniel Bagi, President of Axxess further stated, "We believe the initial sell out of our TapOut pain relief products bodes well for our growth across Canada. We are now we formulating a specific marketing strategy together with the team at Victory to ensure success, and expand into all major retailers in Canada. Victory purchases the inventory it distributes so we know they believe in the products and the strength of the TapouT brand. In addition to the mass retail stores, our product line will be available online at http://www.supplementsource.ca/ and http://www.vitamart.ca/, two of Canada's leading online retail outlets."
About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain to optimal health management through improved nutritional supplements.
For more information, please visit www.axxesspharmainc.com, or contact Investor Relations at (973) 351-3868.
Safe Harbor Statement
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.